Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Assets (2016 - 2025)

Cumberland Pharmaceuticals (CPIX) has disclosed Assets for 16 consecutive years, with $76.8 million as the latest value for Q4 2025.

  • Quarterly Assets rose 1.64% to $76.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $76.8 million through Dec 2025, up 1.64% year-over-year, with the annual reading at $76.8 million for FY2025, 1.64% up from the prior year.
  • Assets hit $76.8 million in Q4 2025 for Cumberland Pharmaceuticals, up from $65.9 million in the prior quarter.
  • In the past five years, Assets ranged from a high of $96.7 million in Q1 2022 to a low of $65.9 million in Q3 2025.
  • Historically, Assets has averaged $83.4 million across 5 years, with a median of $86.0 million in 2021.
  • Biggest five-year swings in Assets: grew 10.02% in 2022 and later fell 14.2% in 2025.
  • Year by year, Assets stood at $84.5 million in 2021, then increased by 10.02% to $92.9 million in 2022, then dropped by 12.0% to $81.8 million in 2023, then decreased by 7.57% to $75.6 million in 2024, then rose by 1.64% to $76.8 million in 2025.
  • Business Quant data shows Assets for CPIX at $76.8 million in Q4 2025, $65.9 million in Q3 2025, and $67.9 million in Q2 2025.